WA
SLXP

WealthTrust-Arizona’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

WealthTrust-Arizona’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-28
Closed -$4K – 701
2014
Q3 		$4K Hold
28
– – ﹤0.01% 524
2014
Q2 		$3K Sell
28
-4
-13% -$442 ﹤0.01% 546
2014
Q1 		$3K Buy
+32
New +$3.28K ﹤0.01% 558

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WealthTrust-Arizona's SLXP Position: Q4 2014 in Review

WealthTrust-Arizona sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 28 shares — an estimated $4K sold.

WealthTrust-Arizona first reported a position in SLXP in Q1 2014 and held it in 3 quarters. The position peaked at $4K in Q3 2014. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • WealthTrust-Arizona reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • WealthTrust-Arizona sold 28 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $4K.
  • WealthTrust-Arizona first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 3 quarters.
  • WealthTrust-Arizona's SALIX PHARMACEUTICALS LTD DEL position peaked at $4K in Q3 2014.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on WealthTrust-Arizona's 13F filing for Q4 2014, filed 22 Jan 2015.